I agree Stezza,
6. The 6-minute walk test distance (6MWTD) measuring patient exercise capacity after aortic
valve replacement improved by 32% from baseline, with a 17% improvement from the 30-day
result at 12 months.
If I read this correctly, 83% of the improvement in exercise tolerance occurred after 30 days and the remaining 17% over the following 11 months.
That is more like 21% improvement experienced over the 11 months (17%) relative to that achieved over the first 30 days (83%) compared to baseline.......not a lot of difference between 17 and 21, but it shows considerable ongoing improvement.
- Forums
- ASX - By Stock
- Ann: DurAVR First in Human Study 12 Month Results
AVR
anteris technologies global corp.
Add to My Watchlist
0.49%
!
$6.12

I agree Stezza, 6. The 6-minute walk test distance (6MWTD)...
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
$6.12 |
Change
-0.030(0.49%) |
Mkt cap ! $94.85M |
Open | High | Low | Value | Volume |
$6.21 | $6.21 | $6.00 | $16.53K | 2.704K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 1000 | $6.01 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$6.08 | 240 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 1000 | 6.010 |
2 | 1624 | 6.000 |
1 | 25 | 5.850 |
1 | 857 | 5.830 |
1 | 900 | 5.780 |
Price($) | Vol. | No. |
---|---|---|
6.080 | 240 | 1 |
6.180 | 50 | 1 |
6.190 | 1000 | 1 |
6.200 | 1000 | 1 |
6.400 | 130 | 1 |
Last trade - 15.46pm 25/06/2025 (20 minute delay) ? |
Featured News
AVR (ASX) Chart |